With the simultaneous use of verapamil with: - antiarrhythmic drugs, beta adrenoblockers and inhalation anesthetics, there is an increase in cardiotoxic effect (increased risk of atrioventricular blockade, a sharp decrease in heart rate, development of heart failure, a sharp drop in blood pressure);
- antihypertensive agents and diuretics - it is possible to strengthen the hypotensive effect of verapamil;
- digoxin may increase the level of digoxin concentration in the blood plasma due to the deterioration of its excretion by the kidneys (so it is necessary to monitor the level of digoxin in the blood plasma in order to determine its optimal dosage and prevent intoxication);
- with cimetidine and ranitidine, the level of concentration of verapamil in the blood plasma increases;
- rifampicin, phenobarbital may decrease the concentration in the blood plasma and weaken the action of verapamil;
- Theophylline, prazosin, cyclosporine may increase the concentration of these substances in the blood plasma; - muscle relaxants may enhance the muscle relaxant effect; Acetylsalicylic acid increases the possibility of bleeding;
- Quinidine increases the concentration of quinidine in the blood plasma, increases the threat of lowering blood pressure, and in patients with hypertrophic cardiomyopathy, the emergence of severe arterial hypotension;
- carbamazepine and lithium, the risk of neurotoxic effects increases.